Compugen Ltd.
A clinical-stage company developing cancer immunotherapies using an AI platform.
CGEN | TA
Overview
Corporate Details
- ISIN(s):
- IL0010852080
- LEI:
- Country:
- Israel
- Address:
- 26 Harokmim St., Bldg D, 5885849 Holon
- Website:
- https://www.cgen.com/
Description
Compugen Ltd. is a clinical-stage therapeutic discovery and development company specializing in cancer immunotherapy. A pioneer in its field, the company leverages a proprietary, broadly applicable, and predictive AI-powered computational discovery platform to identify novel drug targets. Its primary focus is on developing innovative, first-in-class therapeutics designed to modulate the tumor microenvironment and enhance anti-tumor immune responses. Compugen's mission is to advance its pipeline of drug candidates to address patient populations unresponsive to current immunotherapy treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-10-24 15:59 |
Compugen to Release Third Quarter 2023 Results on Tuesday, November 7, 2023,Man…
|
English | 84.0 KB | ||
| 2023-10-24 15:59 |
Compugen to Release Third Quarter 2023 Results on Tuesday, November 7, 2023,Man…
|
English | 36.3 KB | ||
| 2023-10-03 15:59 |
Compugen to Present at Single Cell Genomics 2023 Meeting
|
English | 82.7 KB | ||
| 2023-10-03 15:59 |
Compugen to Present at Single Cell Genomics 2023 Meeting
|
English | 36.0 KB | ||
| 2023-10-02 15:59 |
Compugen Expands Intellectual Property with New Japanese Patent for the Triple …
|
English | 90.4 KB | ||
| 2023-10-02 15:59 |
Compugen Expands Intellectual Property with New Japanese Patent for the Triple …
|
English | 36.1 KB | ||
| 2023-09-27 17:59 |
Compugen to Present New Clinical and Pre-Clinical Data in Multiple Presentation…
|
English | 96.3 KB | ||
| 2023-09-27 17:59 |
Compugen to Present New Clinical and Pre-Clinical Data in Multiple Presentation…
|
English | 36.1 KB | ||
| 2023-09-21 15:59 |
Results of the Annual General Meeting of Shareholders held on September 20, 2023
|
English | 52.0 KB | ||
| 2023-09-21 15:59 |
Results of the Annual General Meeting of Shareholders held on September 20, 2023
|
English | 35.9 KB | ||
| 2023-08-31 15:59 |
Compugen to Present at the H.C. Wainwright 25th Annual Global Investment Confer…
|
English | 84.4 KB | ||
| 2023-08-31 15:59 |
Compugen to Present at the H.C. Wainwright 25th Annual Global Investment Confer…
|
English | 36.0 KB | ||
| 2023-08-23 16:59 |
Form 20-F/A For the fiscal year ended December 31, 2022
|
English | 1.9 MB | ||
| 2023-08-23 16:59 |
Form 20-F/A For the fiscal year ended December 31, 2022
|
English | 36.1 KB | ||
| 2023-08-07 16:58 |
2023 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON WEDNESDAY, SEPTEMBER …
|
English | 262.7 KB |
Automate Your Workflow. Get a real-time feed of all Compugen Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Compugen Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Compugen Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
